Related Experiment Video
Updated: May 15, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
Published on: January 24, 2017
Systematic Production of IgG-Like Bispecific Antibodies via Intein-Mediated Protein Trans-Splicing
Hiroki Akiba1,2, Kouhei Tsumoto3,4,5
1Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan. hakiba@pharm.kyoto-u.ac.jp.
Abstract:
Bispecific antibodies show therapeutic potential; thus, their screening campaign has attracted attention for the development of biotherapeutics. However, many bispecific formats require engineering or fine-tuned purification processes optimized for each molecule, hindering simple screening, especially when impurities are not allowed. In this chapter, we describe a method for producing IgG-like bispecific antibodies via intein-mediated protein trans-splicing, fusing two polypeptide units post-translationally. This method allows the separate expression of two antigen-binding fragments and eliminates the light chain problem. Homobivalent species are not contaminated. In addition, the common purification process finalized by size-exclusion chromatography enables the systematic production of bispecific antibodies suitable for in vitro screening.
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Production of Pharmaceuticals
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

